Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (201)	1/15/2003 1:51:12 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

ISPH Has continued its up-trend without closing its up-gap on October 30.<g> It has been up more than 12% today and volume now is almost up to the 400K and still has a favorable B/A at present. ISPH has had recent regulatory approval of its INS365 for dry-eye, which will be co-market with AGN and its CEO has resisted raising cash while its stock price remained below $10.<g>(ISPH still has about $1.57 in cash/share) Chrity Shaffer reportedly said:"At some point we will have to raise capital, but we don't like the idea of private placements since people want warrants and discounts." <g> The stock has appreciated more than 300% from its October L. siliconinvestor.com And it has now closed a good part of its last year January 15- January 16 down-gap .(Gap from $15.51 to $4.98= 10.53 & middle of gap = $10.25) siliconinvestor.com Bernard